Literature DB >> 28260423

Organ Shortage: Can We Decrease the Demand?

Antoine Stephan1.   

Abstract

The shortage of organs for transplant is a universal problem. The World Health Organization is urging every nation to seek self-sufficiency regarding their organ procurement program. Reaching self-sufficiency inevitably requires the provision of a well-developed deceased-donor organ procurement program. Most countries represented by the Middle East Society for Organ Transplantation still rely on living-donor organ donations. Some of these countries have been relatively successful in promoting deceased-donor donation as well. In our region, deceased-donor organs are recovered exclusively from patients who have been declared brain dead. However, with improvements in preventive and therapeutic interventions, the pool of potential brain dead donors is rapidly shrinking. This should, therefore, stimulate our interest in developing a program for recovering organs after cardiac death. However, increasing the pool of donors, even to optimal levels, may still not be enough to meet the growing demand. More resources must be invested in reducing the demand for organs. This is especially true in our region, where primary care programs aimed at slowing or containing disease progression that may lead to organ failure are lacking. This problem is compounded by limited access to such programs and, for that matter, limited access to even the most basic primary care. Continued efforts to increase the supply of donor organs must be pursued. At the same time, we must work to more effectively treat the diseases that could lead to end-stage renal disease and the increased demand for donor organs. A comprehensive approach to the problem of donor organ shortages in countries in the Middle East also must consider the relatively limited financial resources that are available.

Entities:  

Mesh:

Year:  2017        PMID: 28260423     DOI: 10.6002/ect.mesot2016.L27

Source DB:  PubMed          Journal:  Exp Clin Transplant        ISSN: 1304-0855            Impact factor:   0.945


  6 in total

1.  Opinions and Expectations of Muslim Donors' Relatives Deciding Organ Donation: The Sample of Istanbul.

Authors:  Arzu Kader Harmanci Seren; Hanife Yavuz; Aynur Horoz; Meltem Yıldız
Journal:  J Relig Health       Date:  2018-12

2.  Progenitor-derived human endothelial cells evade alloimmunity by CRISPR/Cas9-mediated complete ablation of MHC expression.

Authors:  Jonathan Merola; Melanie Reschke; Richard W Pierce; Lingfeng Qin; Susann Spindler; Tania Baltazar; Thomas D Manes; Francesc Lopez-Giraldez; Guangxin Li; Laura G Bracaglia; Catherine Xie; Nancy Kirkiles-Smith; W Mark Saltzman; Gregory T Tietjen; George Tellides; Jordan S Pober
Journal:  JCI Insight       Date:  2019-10-17

3.  The impact of neurologically deceased donors' blood pressures on clinical outcomes in transplant recipients: a systematic review.

Authors:  John Basmaji; Christine Reed; Bram Rochwerg; Ian M Ball
Journal:  Can J Anaesth       Date:  2020-06-26       Impact factor: 6.713

4.  Pre-transplant donor HBV DNA+ and male recipient are independent risk factors for treatment failure in HBsAg+ donors to HBsAg- kidney transplant recipients.

Authors:  Xian-Ding Wang; Shi-Jian Feng; Jin-Peng Liu; Tu-Run Song; Zhong-Li Huang; Yu Fan; Yun-Ying Shi; Li-Yu Chen; Yuan-Hang Lv; Zi-Lin Xu; Xiao-Hong Li; Li Wang; Tao Lin
Journal:  BMC Infect Dis       Date:  2021-01-09       Impact factor: 3.090

5.  Coagulation, inflammation, and CD46 transgene expression in neonatal porcine islet xenotransplantation.

Authors:  Mingqing Song; Zachary W Fitch; Kannan P Samy; Benjamin M Martin; Qimeng Gao; Robert Patrick Davis; Francis V Leopardi; Niki Huffman; Robin Schmitz; Gayathri R Devi; Bradley H Collins; Allan D Kirk
Journal:  Xenotransplantation       Date:  2021-02-22       Impact factor: 3.907

6.  The obstacles to organ donation following brain death in Iran: a qualitative study.

Authors:  Parvin Abbasi; Javad Yoosefi Lebni; Paricher Nouri; Arash Ziapour; Amir Jalali
Journal:  BMC Med Ethics       Date:  2020-09-01       Impact factor: 2.652

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.